Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing

Transfusion

Volumn 45, Issue 8, 2005, Pages 1391-1397

  Rodríguez, Luciano ^b   Velasco, Beatriz ^b   García, Joan ^b   Martín Henao, Gregorio Ángel ^a  

^a Duran i Reynals Hospital   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; CD34 ANTIGEN;

ARTICLE; AUTOMATION; BLOOD; CD34 SELECTION; CELL COUNT; CELL VIABILITY; COLONY FORMING UNIT; DEVICE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OSMOLARITY; THAWING; APHERESIS; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISOLATION AND PURIFICATION;

ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 23844437635     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00213.x     Document Type: Article

References (32)

1. Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992;1:233-50.
2. Rowley SD, Anderson GL. Effect of DMSO exposure without cryopreservation on hematopoietic progenitor cells. Bone Marrow Transplant 1993;11:389-93.
3. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990;5(Suppl 1):25-7.
4. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-6.
5. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75: 781-6.
6. Alessandrino P, Bernasconi P, Caldera D, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999;23:533-7.
7. Keung YK, Lau S, Elkayam U, et al. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994;14:363-7.
8. Lopez-Jimenez J, Cervero C, Munoz A, et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994;13:789-93.
9. Higman MA, Port JD, Beauchamp NJ Jr, Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000;26:797-800.
10. Cabezudo E, Dalmases C, Ruz M, et al. Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function. Transfusion 2000;40:1223-7.
11. Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002;42: 1573-80.
12. Bakken AM, Bruserud O, Abrahamsen JF. No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res 2003;12:351-8.
13. Rowley SD, Feng Z, Chen L, et al. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003;31:1043-51.
14. Martino M, Morabito F, Messina G, et al. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996;81:59-61.
15. Shpall EJ, LeMaistre CF, Holland K, et al. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 1997; 90:4313-20.
16. Ayello J, Hesdorffer C, Reiss RF. A semiautomated technique for volume reduction of stem cell suspensions for autotransplantation. J Hematother 1995;4:545-9.
17. Del Mastro L, Venturini M, Viscoli C, et al. Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. Ann Oncol 2001;12:505-8.
18. Beaujean F, Hartmann O, Kuentz M, et al. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991;8:291-4.
19. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-32.
20. Stewart AK, Vescio R, Schiller G, et al. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. J Clin Oncol 2001;19:3771-9.
21. Yanovich S, Mitsky P, Cornetta K, et al. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial. Bone Marrow Transplant 2000;25:1165-74.
22. Menendez P, Redondo O, Rodriguez A, et al. Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry 1998;34:264-71.
23. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society for Hematotherapy Graft Engineering. Cytometry 1998;34:61-70.
24. Capmany G, Querol S, Cancelas JA, Garcia J. Short-term, serum-free, static culture of cord blood-derived CD34+ cells, effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells. Haematologica 1999;84: 675-82.
25. Carpenter JF, Dawson PE. Quantitation of dimethyl sulfoxide in solutions and tissues by high-performance liquid chromatography. Cryobiology 1991;28:210-5.
26. Syme R, Bewick M, Stewart D, et al. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004;10:135-41.
27. Calmels B, Houze P, Hengesse JC, et al. Preclinical evaluation of an automated closed fluid management device: Cytomate (TM), for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003;31:823-8.
28. Perotti C, Del Fante C, Salvaneschi L, et al. A new automated cell washer device for thawed cord blood units. Transfusion 2004;44:900-6.
29. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.
30. Branch DR, Calderwood S, Cecutti MA, et al. Hematopoietic progenitor cells are resistant to dimethyl sulfoxide toxicity. Transfusion 1994;34:887-90.
31. Douay L, Gorin NC, David R, et al. Study of granulocyte-macrophage progenitor (CFUc) preservation after slow freezing of bone marrow in the gas phase of liquid nitrogen. Exp Hematol 1982;10:360-6.
32. Humpe AV, Vehmeyer K, Riggert J, et al. DMSO significantly reduces the proliferative potential of peripherial blood stem cells after cryopreservation. Bone Marrow Transplant 2000;25:S1-S257.